Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Gilbert

Showing results (161-170 of 337) with videos related to

Pageof 34
Sort By:
Science Translational Medicine|October 20, 2020
Prospects for a safe COVID-19 vaccineBarton F Haynes, Lawrence Corey, Prabhavathi Fernandes, et al.
Statistical Communications in Infectious Diseases|November 28, 2012
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensPeter B Gilbert, Douglas Grove, Erin Gabriel, et al.
Vaccine|January 30, 2017
Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trialsYunda Huang, Lily Zhang, Holly Janes, et al.
Vaccine|December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trialsYunda Huang, Shelly T Karuna, Holly Janes, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 28, 2020
Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countriesYing Huang, Zoe Moodie, Michal Juraska, et al.
Virology|March 8, 2006
Interactive association of proviral load and IFN-gamma-secreting T cell responses in HIV-1C infectionVladimir A Novitsky, Peter B Gilbert, Kimberly Shea, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current EvidenceBrett Hanscom, Holly E Janes, Peter D Guarino, et al.
Journal of Virology|March 8, 2013
HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacityMorgane Rolland, Siriphan Manocheewa, J Victor Swain, et al.
Emerging Infectious Diseases|January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 InfectionDavid S Khoury, Timothy E Schlub, Deborah Cromer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 20, 2019
Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01Yunda Huang, Yuanyuan Zhang, Robert Bailer, et al.
Pageof 34

Showing results (161-170 of 337) with videos related to

Sort By:
Pageof 34
Science Translational Medicine|October 20, 2020
Prospects for a safe COVID-19 vaccineBarton F Haynes, Lawrence Corey, Prabhavathi Fernandes, et al.
Statistical Communications in Infectious Diseases|November 28, 2012
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine RegimensPeter B Gilbert, Douglas Grove, Erin Gabriel, et al.
Vaccine|January 30, 2017
Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trialsYunda Huang, Lily Zhang, Holly Janes, et al.
Vaccine|December 3, 2014
Use of placebos in Phase 1 preventive HIV vaccine clinical trialsYunda Huang, Shelly T Karuna, Holly Janes, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 28, 2020
Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countriesYing Huang, Zoe Moodie, Michal Juraska, et al.
Virology|March 8, 2006
Interactive association of proviral load and IFN-gamma-secreting T cell responses in HIV-1C infectionVladimir A Novitsky, Peter B Gilbert, Kimberly Shea, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2016
Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current EvidenceBrett Hanscom, Holly E Janes, Peter D Guarino, et al.
Journal of Virology|March 8, 2013
HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacityMorgane Rolland, Siriphan Manocheewa, J Victor Swain, et al.
Emerging Infectious Diseases|January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 InfectionDavid S Khoury, Timothy E Schlub, Deborah Cromer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 20, 2019
Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01Yunda Huang, Yuanyuan Zhang, Robert Bailer, et al.
Pageof 34